Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Department of Haematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.
Acta Clin Belg. 2022 Apr;77(2):280-285. doi: 10.1080/17843286.2020.1829252. Epub 2020 Oct 3.
COVID-19 predisposes patients to thrombotic disease. The aim of this guidance document is to provide Belgian health-care workers with recommendations on anticoagulation management in COVID-19 positive patients.
These recommendations were based on current knowledge and a limited level of evidence.
We formulated recommendations for the prophylaxis and treatment of COVID-related venous thromboembolism in ambulatory and hospitalised patients, as well as recommendations for the use of antithrombotic drugs in patients with prior indication for anticoagulation who develop COVID-19.
These recommendations represent an easy-to-use practical guidance that can be implemented in every Belgian hospital and be used by primary care physicians and gynaecologists. Of note, they are likely to evolve with increased knowledge of the disease and availability of data from ongoing clinical trials.
COVID-19 使患者易患血栓疾病。本指导文件的目的是为比利时医护人员提供 COVID-19 阳性患者抗凝治疗管理的建议。
这些建议基于现有知识和有限的证据水平。
我们制定了针对门诊和住院患者 COVID 相关静脉血栓栓塞症预防和治疗的建议，以及针对因其他原因需要抗凝治疗而又感染 COVID-19 的患者使用抗血栓药物的建议。
这些建议代表了一种易于使用的实用指南，可在比利时的每所医院实施，并可由初级保健医生和妇科医生使用。值得注意的是，随着对该疾病认识的提高以及正在进行的临床试验数据的可用性，这些建议可能会发生变化。
